ANI PHARMACEUTICALS INC — Director's Dealing 2012

Mar 30, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOSANTE PHARMACEUTICALS INC (BPAX)
CIK: 0001023024
Period of Report: 2012-03-30

Reporting Person: MANGANO ROSS J (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-03-30	Non-Statutory Stock Option (right to buy)	$0.68	A	25000	Acquired	2022-03-29	Common Stock (25000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	73333	Indirect
Common Stock	1929661	Indirect
Common Stock	30000	Indirect
Common Stock	33333	Indirect
Common Stock	33333	Indirect
Common Stock	100000	Indirect
Common Stock	165756	Direct

Footnotes

F1: Shares are held indirectly by Mr. Mangano in various trusts of which Mr. Mangano is the trustee.

F2: Shares are held by Oliver & Co., of which Mr. Mangano is a trustee.

F3: Shares are indirectly held by Mr. Mangano as an investment advisor on behalf of an individual.